Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Feb 21;19(2):118.
doi: 10.3390/md19020118.

α-Conotoxins and α-Cobratoxin Promote, while Lipoxygenase and Cyclooxygenase Inhibitors Suppress the Proliferation of Glioma C6 Cells

Affiliations
Comparative Study

α-Conotoxins and α-Cobratoxin Promote, while Lipoxygenase and Cyclooxygenase Inhibitors Suppress the Proliferation of Glioma C6 Cells

Tatiana I Terpinskaya et al. Mar Drugs. .

Abstract

Among the brain tumors, glioma is the most common. In general, different biochemical mechanisms, involving nicotinic acetylcholine receptors (nAChRs) and the arachidonic acid cascade are involved in oncogenesis. Although the engagement of the latter in survival and proliferation of rat C6 glioma has been shown, there are practically no data about the presence and the role of nAChRs in C6 cells. In this work we studied the effects of nAChR antagonists, marine snail α-conotoxins and snake α-cobratoxin, on the survival and proliferation of C6 glioma cells. The effects of the lipoxygenase and cyclooxygenase inhibitors either alone or together with α-conotoxins and α-cobratoxin were studied in parallel. It was found that α-conotoxins and α-cobratoxin promoted the proliferation of C6 glioma cells, while nicotine had practically no effect at concentrations below 1 µL/mL. Nordihydroguaiaretic acid, a nonspecific lipoxygenase inhibitor, and baicalein, a 12-lipoxygenase inhibitor, exerted antiproliferative and cytotoxic effects on C6 cells. nAChR inhibitors weaken this effect after 24 h cultivation but produced no effects at longer times. Quantitative real-time polymerase chain reaction showed that mRNA for α4, α7, β2 and β4 subunits of nAChR were expressed in C6 glioma cells. This is the first indication for involvement of nAChRs in mechanisms of glioma cell proliferation.

Keywords: cyclooxygenase inhibitor; glioma C6; lipoxygenase inhibitor; proliferation; real-time polymerase chain reaction; viability; α-cobratoxin; α-conotoxin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
The effect of α-conotoxins MII; PnIA; RgIA; [V11L,V16D]ArIB ([L,D]ArIB) and α-cobratoxin (CTX) at concentration of 1 nM on the viability (a) and on the proliferative activity (b) of C6 glioma cells after 24 h (n = 20), 48 h (n = 20), and 72 h (n = 10–12) of incubation. The cell viability and concentration were determined by flow cytometry. * p < 0.05 according to Student’s t-test when compared to control.
Figure 2
Figure 2
Effect of CTX on the survival of rat C6 glioma cells. The cells were incubated in the presence of various CTX concentrations (3 pM–3 μM) for 72 h. Cytotoxin I (Cyt I) from Naja oxiana venom was used for a positive control. The cell viability was determined by MTT test. Data are shown as % of control (untreated cells). The results are presented as the mean ± SEM in three (for concentrations of 3 nM and 300 pM—four) independent experiments with 12 replicates in each. * p < 0.05, Student’s two-sample t-test compared to control.
Figure 3
Figure 3
Glioma C6 cells treated with nicotine at a concentration of 1 μL/mL (6.1 mM).
Figure 4
Figure 4
Effect of α-conotoxins MII; PnIA; RgIA; [V11L,V16D]ArIB ([L,D]ArIB) and α-cobratoxin (CTX) at concentration of 1 nM and COX inhibitors (IM, indomethacin, 10 µМ; NS-560, 5 µM; SC-398, 0.1 µM) applied separately or in the indicated combinations on viability (a) and on the proliferative activity (b) of C6 glioma cells after 24 h (n = 10), 48 h (n = 15) and 72 h (n = 10) of incubation. The cell viability and concentration were determined by flow cytometry. * p < 0.05 according to Student’s t-test when compared to control; ** p < 0.05 according to Student’s t-test when compared to the corresponding COX inhibitor.
Figure 5
Figure 5
Effect of α-conotoxins MII; PnIA; RgIA; [V11L,V16D]ArIB ([L,D]ArIB) and α-cobratoxin (CTX) at concentration of 1 nM and LOX inhibitors (NDGA, nordihydroguaiaretic acid, 30 µM; Bai, baicalein, 50 µM; Zil, zileuton, 50 µM) on the viability (a) and on the proliferative activity (b) of glioma C6 cells after 24 h (n = 15), 48 h (n = 14) and 72 h (n = 15) of incubation. (c) Effect of the combined use of NDGA and COX inhibitors (IM, indomethacin, 10 µМ; NS-560, 5 µM; SC-398, 0.1 µM) with the α7 nAChR blockers on the proliferation of C6 glioma cells after 24 h of incubation (n = 5). The cell viability and concentration were determined by flow cytometry. * p < 0.05 according to Student’s t-test when compared to control; ** p < 0.05 according to Student’s t-test when compared with the corresponding LOX/COX inhibitor.
Figure 6
Figure 6
Real-time PCR detection of mRNA for nAChR subunits. Only α4, α7, β2 and β4 subunits were detected. ΔCT values normalized to the α7 ΔCT value are shown. Results are presented as mean ± SE of two independent experiments. Not detected, n.d.
Figure 7
Figure 7
Binding of radioactive 125I-labeled α-bungarotoxin (125I-αBgt) to glioma C6 cells. Nonspecific 125I-αBgt binding was determined in the presence of 200-fold excess of CTX. Results are presented as mean ± SE of two independent experiments (n = 5 in each experiment).

References

    1. Friedman J.R., Richbart S.D., Merritt J.C., Brown K.C., Nolan N.A., Akers A.T., Lau J.K., Robateau Z.R., Miles S.L., Dasgupta P. Acetylcholine signaling system in progression of lung cancers. Pharmacol. Ther. 2019;194:222–254. doi: 10.1016/j.pharmthera.2018.10.002. - DOI - PMC - PubMed
    1. Zhang Y., Jia Y., Li P., Li H., Xiao D., Wang Y., Ma X. Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation. J. Genet. Genom. 2017;44:355–362. doi: 10.1016/j.jgg.2017.03.003. - DOI - PubMed
    1. Gankhuyag N., Lee K.-H., Cho J.-Y. The Role of Nitrosamine (NNK) in Breast Cancer Carcinogenesis. J. Mammary Gland. Biol. Neoplasia. 2017;22:159–170. doi: 10.1007/s10911-017-9381-z. - DOI - PMC - PubMed
    1. Shin V.Y., Jin H.C., Ng E.K., Yu J., Leung W.K., Cho C.H., Sung J.J. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways. Toxicol. Appl. Pharmacol. 2008;233:254–261. doi: 10.1016/j.taap.2008.08.012. - DOI - PubMed
    1. Shin V.Y., Wu W.K., Ye Y.-N., So W.H., Koo M.W., Liu E.S., Luo J.-C., Cho C.-H. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis. 2004;25:2487–2495. doi: 10.1093/carcin/bgh266. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources